HUE056401T2 - Topikális készítmények és kezelések - Google Patents

Topikális készítmények és kezelések

Info

Publication number
HUE056401T2
HUE056401T2 HUE16828382A HUE16828382A HUE056401T2 HU E056401 T2 HUE056401 T2 HU E056401T2 HU E16828382 A HUE16828382 A HU E16828382A HU E16828382 A HUE16828382 A HU E16828382A HU E056401 T2 HUE056401 T2 HU E056401T2
Authority
HU
Hungary
Prior art keywords
treatments
topical formulations
topical
formulations
Prior art date
Application number
HUE16828382A
Other languages
English (en)
Inventor
Hemant Alur
James Harwick
Original Assignee
Trilogic Pharma Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trilogic Pharma Llc filed Critical Trilogic Pharma Llc
Publication of HUE056401T2 publication Critical patent/HUE056401T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HUE16828382A 2015-07-20 2016-07-18 Topikális készítmények és kezelések HUE056401T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562194518P 2015-07-20 2015-07-20

Publications (1)

Publication Number Publication Date
HUE056401T2 true HUE056401T2 (hu) 2022-02-28

Family

ID=57835134

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE16828382A HUE056401T2 (hu) 2015-07-20 2016-07-18 Topikális készítmények és kezelések

Country Status (11)

Country Link
US (2) US11129896B2 (hu)
EP (1) EP3324938B1 (hu)
CA (2) CA3209380A1 (hu)
DK (1) DK3324938T3 (hu)
ES (1) ES2891754T3 (hu)
HU (1) HUE056401T2 (hu)
LT (1) LT3324938T (hu)
MX (2) MX2018000800A (hu)
PL (1) PL3324938T3 (hu)
PT (1) PT3324938T (hu)
WO (1) WO2017015232A1 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112018015143A2 (pt) 2016-02-09 2018-12-18 Bracco Suisse Sa proteína quimérica recombinante para direcionamento de selectinas
US20240165141A1 (en) * 2021-07-26 2024-05-23 Daré Bioscience, Inc. Systems and methods for treatment of bacterial vaginosis
JP2024529479A (ja) * 2021-07-26 2024-08-06 デア バイオサイエンス， インコーポレイテッド 膣挿入のための組成物及び技術
WO2024155775A2 (en) * 2023-01-19 2024-07-25 Dare Bioscience, Inc. Compositions and techniques for treatment of polycystic ovarian syndrome (pcos) and endometriosis
WO2024155777A2 (en) * 2023-01-19 2024-07-25 Dare Bioscience, Inc. Compositions and techniques for treatment of polycystic ovarian syndrome (pcos) and endometriosis
WO2024158951A2 (en) * 2023-01-25 2024-08-02 Dare Bioscience, Inc. Compositions and methods for treating dysmenorrhea

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1120001C (zh) * 1997-11-24 2003-09-03 曾忠铭 刺激阴道革兰氏阳性杆菌生长、增强阴道酸度的药剂和其用途
US20040167223A1 (en) * 2002-09-03 2004-08-26 Popp Karl F. Topical antibacterial formulations
CN1311873C (zh) * 2004-06-30 2007-04-25 上海复康医药科技发展有限公司 一种温度敏感的阴道用原位凝胶制剂
WO2009073658A1 (en) * 2007-12-03 2009-06-11 Trilogic Pharma Llc Self solidifying bioerodible barrier implant
WO2009090558A2 (en) * 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US20100105750A1 (en) 2008-10-23 2010-04-29 Nycomed Us Inc. Stable metronidazole gel formulations
CN102525884A (zh) 2010-12-19 2012-07-04 复旦大学 一种用于阴道给药的温敏原位凝胶制剂

Also Published As

Publication number Publication date
ES2891754T3 (es) 2022-01-31
CA2993012A1 (en) 2017-01-26
US20180207275A1 (en) 2018-07-26
WO2017015232A1 (en) 2017-01-26
US11129896B2 (en) 2021-09-28
CA2993012C (en) 2023-10-03
PL3324938T3 (pl) 2022-01-10
EP3324938A1 (en) 2018-05-30
MX2022001736A (es) 2022-03-11
EP3324938A4 (en) 2019-03-13
EP3324938B1 (en) 2021-09-01
US20220040306A1 (en) 2022-02-10
CA3209380A1 (en) 2017-01-26
LT3324938T (lt) 2021-11-25
DK3324938T3 (da) 2021-09-27
MX2018000800A (es) 2018-08-16
PT3324938T (pt) 2021-09-21

Similar Documents

Publication Publication Date Title
HK1248526A1 (zh) 包含大麻萜酚的化妝品和局部施用組合物
IL259570A (en) Combined therapy and their uses and methods
SG11201701292XA (en) Topical formulation
ZA201904704B (en) Topical cyclosporine-containing formulations and uses thereof
EP3334429C0 (en) HYPERPHENYLALANINEMIA AND TREATMENTS THEREFOR
EP3328353A4 (en) TOPICAL SKIN FORMULATIONS
EP3324925A4 (en) TOPICAL SKIN FORMULATIONS
HK1231376A1 (zh) 局部製劑及其應用
HUE056401T2 (hu) Topikális készítmények és kezelések
HK1247827A1 (zh) 局部治療組合物
SG11201706938XA (en) Topical formulation
IL268583A (en) Preparations and methods for use on the skin
EP3328354A4 (en) TOPICAL SKIN FORMULATIONS
EP3373924A4 (en) TOPICAL FORMULATIONS AND USES THEREOF
EP3311790A4 (en) HAIR TREATMENT AGENT
ZA201803987B (en) Topical skin care compositions comprising myrsine africana extracts
PL3373976T3 (pl) Preparaty do stosowania miejscowego i ich zastosowanie
EP3302530A4 (en) Cdh26 based therapeutic agents and their use
HK1244684A1 (zh) 角蛋白處理
EP3525767A4 (en) TOPICAL FORMULATIONS AND TREATMENTS
GB2557383B (en) Hair treatments
IL272945A (en) Local preparations and methods of treatment
ZA201802201B (en) Novel formulation and treatment methods
GB201709850D0 (en) Hair treatments
PL3349722T3 (pl) Miejscowe leczenie hirsutyzmu